Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Drury Capital gains 8.13% in April (+14.39% YTD), defies commodities market sell-off

Wednesday, May 15, 2013

amb
Bill Miller
From Komfie Manalo, Opalesque Asia – Drury Capital defied the commodities market sell-off in April after its Diversified Trend-Following Program gained 8.13% last month (+14.39% YTD). This strong performance comes at a time when many commodities hedge funds are struggling to make gains.

Drury’s Commodity Investment Strategy is featured in our A-Square Database which can be found here.

Bill Miller, Head of Global Sales for Drury commented," We are cautiously optimistic that the tide is turning. CTAs can be long or short and we are agile enough to make the most of market activity, making sure we are on the ball to catch market trends and this has given us the edge in April. Many investors have money tied up in equities, which have performed well, but historically we know the economic cycle will turn in time. It could be argued that the markets have recently shown signs of retuning to a more normal state, and it appears in certain cases, commodity prices are perhaps less influenced by risk-on/risk-off buying and selling, and perhaps have given way to price moves based on primarily market fundamentals. We know the markets can fluctuate dramatically but we are seeing signs that there is a turnaround beginning to appear."

Indeed Drury’s Commodity Investment Strategy provided a healthy gain f......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its